Clinical Trial Update: A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients [EARLY_Phase 1]

View source ↗

Summary

A randomized controlled trial evaluating topical 5% niacinamide for prevention of skin cancer in organ transplant recipients is in early phase and not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Cutaneous Squamous Cell Carcinoma
• Skin Cancer

Drugs mentioned

• Niacinamide (topical, 5%) (niacinamide)

Snippet

Sponsor: Marissa Lobl | Conditions: Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING